JH
Jagiyassi Harish Kumar
About Jagiyassi Harish Kumar
Data last updated:
Jagiyassi Harish Kumar is a Director at Neocell Science Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Neocell Science Pharmaceuticals Private Limited reported revenue of ₹3.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neocell Science Pharmaceuticals Private Limited U51909TG2019PTC135631 | Director | 23 Sep 2019 | 2019 | ₹3.61 Cr (FY 2024) | Active |
Board colleagues of Jagiyassi Harish Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagiyassi Nirmala | 08569898 | Neocell Science Pharmaceuticals Private Limited | Director |
| Nagaraju Nallagatla | 08569899 | Neocell Science Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagiyassi Harish Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagiyassi Harish Kumar
Jagiyassi Harish Kumar currently holds 1 directorship: Neocell Science Pharmaceuticals Private Limited (Director, since 23 Sep 2019, revenue ₹3.61 Cr (FY 2024)).
Jagiyassi Harish Kumar was first appointed on 23 Sep 2019 as Director at Neocell Science Pharmaceuticals Private Limited.
The current boards of Jagiyassi Harish Kumar's companies include Jagiyassi Nirmala (Neocell Science Pharmaceuticals Private Limited), Nagaraju Nallagatla (Neocell Science Pharmaceuticals Private Limited).